(Q34248416)

31 July 2017

1 reference

title

A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections (English)

1 reference

31 July 2017

1 reference

S J Martin

1

1 reference

31 July 2017

R Jung

series ordinal

2

1 reference

31 July 2017

C G Garvin

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

199-222

1 reference

Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group

31 July 2017

cites work

1 reference

12 December 2020

Drug-drug interactions with fluoroquinolones.

1 reference

12 December 2020

Toxicity of quinolone antimicrobial agents

1 reference

12 December 2020

Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers

1 reference

12 December 2020

Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Current concepts in long QT syndrome

1 reference

12 December 2020

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

1 reference

12 December 2020

The withdrawal of temafloxacin. Are there implications for other quinolones?

1 reference

12 December 2020

[Levofloxacin-induced tendinitis]

1 reference

12 December 2020

Quinolone arthropathy in animals versus children

1 reference

12 December 2020

Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).

1 reference

12 December 2020

QT interval prolongation and torsades de pointes due to erythromycin lactobionate

1 reference

12 December 2020

The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility

1 reference

12 December 2020

Central nervous system toxicity of quinolones: human and animal findings

1 reference

12 December 2020

Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites

1 reference

12 December 2020

A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects

1 reference

12 December 2020

Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study

1 reference

12 December 2020

Potential interactions of the extended-spectrum fluoroquinolones with the CNS.

1 reference

12 December 2020

QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults

1 reference

12 December 2020

Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study

1 reference

12 December 2020

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

1 reference

12 December 2020

The future of the quinolones

1 reference

12 December 2020

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

1 reference

12 December 2020

A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection

1 reference

12 December 2020

Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients

1 reference

12 December 2020

Fluoroquinolone induced tendinopathy: report of 6 cases

1 reference

12 December 2020

A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis

1 reference

12 December 2020

Resistance in respiratory tract pathogens: an international study 1997-1998

1 reference

12 December 2020

Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients

1 reference

12 December 2020

A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis

1 reference

12 December 2020

Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin

1 reference

12 December 2020

Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis

1 reference

12 December 2020

The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

1 reference

12 December 2020

An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia

1 reference

12 December 2020

Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections

1 reference

12 December 2020

Fluoroquinolone use and fluoroquinolone resistance: is there an association?

1 reference

12 December 2020

Levofloxacin does not alter cyclosporine disposition

1 reference

12 December 2020

Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults

1 reference

12 December 2020

Effects of fluoroquinolones on HERG currents

1 reference

12 December 2020

Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin

1 reference

12 December 2020

Clinical use of fluoroquinolones in children

1 reference

12 December 2020

The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.

1 reference

12 December 2020

Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine

1 reference

12 December 2020

A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Management of fluoroquinolone resistance in Pseudomonas aeruginosa--outcome of monitored use in a referral hospital.

1 reference

12 December 2020

Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections

1 reference

12 December 2020

Safety profile of the quinolones

1 reference

12 December 2020

Specific toxicologic aspects of the quinolones.

1 reference

12 December 2020

Mechanism of differential activities of ofloxacin enantiomers

1 reference

12 December 2020

Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial

1 reference

12 December 2020

Expanded activity and utility of the new fluoroquinolones: a review

1 reference

12 December 2020

Fluoroquinolone toxicity profiles: a review focusing on newer agents

1 reference

12 December 2020

Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.

1 reference

12 December 2020

Comparative in vitro activity and pharmacodynamics of five fluoroquinolones against clinical isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Clinical efficacy of levofloxacin in elderly patients with respiratory tract infections

1 reference

12 December 2020

Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.

1 reference

12 December 2020

Classification and structure-activity relationships of fluoroquinolones

1 reference

12 December 2020

A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia

1 reference

12 December 2020

Partial Achilles tendon ruptures associated with fluoroquinolone antibiotics: a case report and literature review

1 reference

12 December 2020

Photoreaction potential of orally administered levofloxacin in healthy subjects

1 reference

12 December 2020

Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae

1 reference

12 December 2020

Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder

1 reference

12 December 2020

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program

1 reference

12 December 2020

Toxicity of quinolones

1 reference

12 December 2020

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

12 December 2020

Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers

1 reference

12 December 2020

Levofloxacin-induced bilateral Achilles tendonitis

1 reference

12 December 2020

In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates

1 reference

12 December 2020

Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms

1 reference

12 December 2020

Seizures associated with ofloxacin therapy

1 reference

12 December 2020

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

1 reference

12 December 2020

Overview of fluoroquinolone safety

1 reference

12 December 2020

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

1 reference

12 December 2020

Quinolone drug rash in a patient with infectious mononucleosis

1 reference

12 December 2020

Ofloxacin-induced seizure

1 reference

12 December 2020

Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora

1 reference

12 December 2020

Temafloxacin syndrome: review of 95 cases

1 reference

12 December 2020

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

1 reference

12 December 2020

Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00002018-200124030-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1053188794

0 references

1 reference